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ABSTRACT
The function of a protein that has no sequence homo-
log ofknownfunction is difficult toassignon thebasis
of sequence similarity. The same problem may arise
for homologous proteins of different functions if one
is newly discovered and the other is the only known
protein of similar sequence. It is desirable to explore
methods that are not based on sequence similarity.
One approach is to assign functional family of a
protein to provide useful hint about its function.
Several groups have employed a statistical learning
method, support vector machines (SVMs), for predict-
ing protein functional family directly from sequence
irrespective of sequence similarity. These studies
showed that SVM prediction accuracy is at a level use-
ful for functional family assignment. But its capabil-
ity for assignment of distantly related proteins and
homologous proteins of different functions has not
been critically and adequately assessed. Here SVM is
tested for functional family assignment of two groups
of enzymes. One consists of 50 enzymes that have no
homolog of known function from PSI-BLAST search
of protein databases. The other contains eight pairs of
homologous enzymes of different families. SVM cor-
rectly assigns 72% of the enzymes in the first group
and 62% of the enzyme pairs in the second group,
suggesting that it is potentially useful for facilitating
functional study of novel proteins. A web version
of our software, SVMProt, is accessible at http://
jing.cz3.nus.edu.sg/cgi-bin/svmprot.cgi.
INTRODUCTION
Protein functional assignment has been conducted primarily
by sequence similarity, clustering and pattern identification
methods (1–7). These methods tend to become less effective
for novel proteins that have no homolog or whose homolog is
of different function (4,5,7,8). Genomes are known to
contain a substantial portion of such novel proteins. For
instance, 20–100% of the unknown putative protein-coding
open reading frames in a number of recently sequenced
viral genomes (9–12) are without a single homolog in
Swiss-Prot database (13) based on PSI-BLAST search of
that database as of September 2004. Hence, there is a need
for exploring other functional prediction methods (14,15).
Alternative approaches have been developed that explore
structural features (16,17), interaction profiles (18,19), pro-
tein/gene fusion data (20,21) and functional family assignment
by using statistical learning methods including discretized
naı¨ve Bayes, C4.5 decision trees, and instance-based leaning
(22), neural networks (23) and support vector machines
(SVMs) (22,24–29).
In particular, the possibility of using SVM for functional
family assignment of distantly related proteins and homolog-
ous proteins of different functions has been raised based on
testing results of a relatively small number of such proteins
(25,27). However, the proteins used in these studies were
selected based on BLAST instead of PSI-BLAST results.
PSI-BLAST (30) is known to be significantly more sensitive
to proteins of weak similarities than BLAST (1). Therefore,
proteins selected based on PSI-BLAST results can, in a more
critical manner, better test the capability of SVM functional
classification of distantly related proteins, particularly those
whose function cannot be assigned by sequence alignment and
clustering methods. Moreover, the number of proteins used in
earlier studies is relatively small, which may not be sufficient
for testing the performance of SVM assignment of functional
family of novel proteins.
In this work, two groups of enzymes, obtained from
unbiased search of protein databases and literatures and sub-
sequently verified by PSI-BLAST, are used to assess the
capability of SVM for predicting the functional family of
novel proteins. One group includes enzymes that are without
a homolog in the protein databases based on PSI-BLAST
search of these databases. A similarity E-value threshold of
0.05 is used for homolog searching to ensure maximum ex-
clusion of enzymes that have a homolog. The second group
contains pairs of homologous enzymes of different families.
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A stricter similarity E-value threshold of 106 is used for
selecting these enzyme pairs to ensure minimum inclusion
of non-homologous pairs. In the hypothetical situation that
one enzyme in a pair of homologous enzymes of different
families is newly discovered and the other is the only
known protein of similar sequence, the function of the first
enzyme can be incorrectly assigned to that of the second en-
zyme by using sequence similarity methods. Thus, it is of
interest to examine to what extent SVM can be used as an
alternative approach for facilitating functional assignment for
these enzymes. These two groups of enzymes are further
checked to remove those that are in the SVM training sets.
SVM is based on the structural risk minimization principle
from statistical learning theory (31). For each protein func-
tional family, it constructs a hyperplane either in an input
space or a higher-dimensional hyper-space to maximally sep-
arate two groups of proteins, one group is composed of mem-
bers and the other is composed of non-members of that family.
Proteins in a training set, represented by their sequence-
derived physicochemical properties, are projected onto this
hyperspace where members of a family are separated from
the non-members by a hyperplane whose parameters are
adjusted by using a testing set of proteins. By projecting a
new sequence onto the hyperspace, this SVM system can be
used to determine whether it is a member of that family based
on its location with respect to the hyperplane.
SVM classifies proteins into functional families defined
from activities and physicochemical properties rather than
sequence similarity (19,22,24,25,27,28,32). These families
are composed of multiple homolog groups and some distantly
related proteins. The accuracy of SVM depends on the divers-
ity of the protein samples, the quality of the representation of
protein properties, and the efficiency of the statistical learning
algorithm. To a certain extent, no sequence similarity is
required per se. Thus SVM is an attractive approach for
facilitating the functional assignment of novel proteins.
METHODS
SVM protein functional family assignment system is
developed in the following manner. First, every protein
sequence is represented by specific feature vector assembled
from encoded representations of tabulated residue properties
including amino acid composition, hydrophobicity, normal-
ized Van der Waals volume, polarity, polarizability, charge,
surface tension, secondary structure and solvent accessibility
for each residue in the sequence (19,22,24,25,32–34). Similar
types of features have been successfully used for predicting
enzyme functional (22) and structural classes (22,32) by using
statistical learning methods.
Amino acid composition can be straightforwardly com-
puted. Methods for computing each of the other properties
can be found from the literature (19,24,25,33,34). For each
of these properties, amino acids are divided into three groups
such that those in a particular group are regarded to have the
same property. For instance, amino acids can be divided into
hydrophobic (CVLIMFW), neutral (GASTPHY) and polar
(RKEDQN) groups. The groupings of amino acids for each
of the properties are given in Table 1. Three descriptors, com-
position (C), transition (T) and distribution (D), are used to
describe global composition of each of the properties. C is the
number of amino acids of a particular property (such as hydro-
phobicity) divided by the total number of amino acids in a
protein sequence. T characterizes the percent frequency with
which amino acids of a particular property is followed by
amino acids of a different property. D measures the chain
length within which the first, 25, 50, 75 and 100% of the
amino acids of a particular property is located respectively.
A hypothetical protein sequence AEAAAEAEEAAAAAE-
AEEEAAEEAEEEAAE, as shown in Figure 1, has 16 alanines
(n1 = 16) and 14 glutamic acids (n2 = 14). The compositions for
these two amino acids are n1 · 100.00/(n1 + n2) = 53.33 and
n2 · 100.00/(n1 + n2) = 46.67, respectively. There are
15 transitions from A to E or from E to A in this sequence
and the percent frequency of these transitions is (15/
29) · 100.00 = 51.72. The first, 25, 50, 75 and 100% of As
are located within the first 1, 5, 12, 20, and 29 residues, re-
spectively. The D descriptor for As is thus 1/30 · 100.00 =
3.33, 5/30 · 100.00 = 16.67, 12/30 · 100.00 = 40.0, 20/
30 · 100.00 = 66.67, 29/30 · 100.00 = 96.67. Likewise,
the D descriptor for Es is 6.67, 26.67, 60.0, 76.67, 100.0.
Overall, the amino acid composition descriptors for this
sequence are C = (53.33, 46.67), T = (51.72), and D = (3.33,
16.67, 40.0, 66.67, 96.67, 6.67, 26.67, 60.0, 76.67, 100.0),
respectively. Descriptors for other properties can be computed
by a similar procedure.
Overall, there are 21 elements representing these three
descriptors: 3 for C, 3 for T and 15 for D (19,25). The feature
vector of a protein is constructed by combining the 21 elements
of all of these properties and the 20 elements of amino acid
composition in sequential order. Table 2 gives the computed
descriptors of the human insulin precursor (Swiss-Prot acces-
sion no. P01308). The feature vector of a protein is constructed
by combining all of the descriptors in sequential order.
SVM is then trained by using representative proteins of a
particular functional family (positive samples) and those that
are outside this family (negative samples). The positive sam-
ples of a family include all of the known distinct proteins in
that family. Because of the enormous number of proteins, the
size of negative samples needs to be restricted to a manageable
level by using a minimum set of representative proteins. One
way for choosing representative proteins is to select one or a
few distinct proteins from each protein domain family.
The negative samples of a family can be selected from seed
Table 1. Division of amino acids into three different groups for different
physicochemical properties
Property Group 1 Group 2 Group 3
Hydrophobicity
Type Polar Neutral Hydrophobic
Amino acids in the group RKEDQN GASTPHY CVLIMFW
Van der Waals volume
Value 0–2.78 2.95–4.0 4.43–8.08
Amino acids in the group GASCTPD NVEQIL MHKFRYW
Polarity
Value 4.9–6.2 8.0–9.2 10.4–13.0
Amino acids in the group LIFWCMVY PATGS HQRKNED
Polarizability
Value 0–0.108 0.128–0.186 0.219–0.409
Amino acids GASDT CPNVEQIL KMHFRYW
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proteins of the 7316 curated protein families (domain-based)
in the Pfam database (35) excluding those families that have at
least one member belonging to the functional class. Pfam
families are constructed on the basis of sequence similarity.
The purpose of using Pfam proteins is to ensure that the
negative samples are evenly distributed in the protein space.
Sequence similarity is not required for selecting positive sam-
ples. In this sense, SVMProt is to some extent independent of
sequence similarity.
The theory of SVM has been described in the literature
(19,24,25,33,34). Thus only a brief description is given
here. In linearly separable cases, SVM constructs a hyperplane
that separates two different groups of feature vectors with a
maximum margin. A feature vector is represented by xi, with
physicochemical descriptors of a protein as its components.
The hyperplane is constructed by finding another vector w and
a parameter b that minimizeskwk2 and satisfies the following
conditions:
wxi + b  + 1, for yi = þ1 Group 1 positiveð Þ, 1
wxi + b  1, for yi = 1 Group 2 negativeð Þ, 2
where yi is the group index, w is a vector normal to the hyper-
plane, j b j /kwk is the perpendicular distance from the hyper-
plane to the origin and kwk2 is the Euclidean norm of w.
After the determination of w and b, a given vector x can be
classified by
sign wxð Þ + b½  3
In nonlinearly separable cases, SVM maps feature vectors
into a high dimensional feature space using a kernel function
K(xi, xj). An example of a kernel function is the Gaussian
kernel, which has been extensively used in a number of protein
classification studies (19,24,26,31,33,34,36):
K xi, xj
 
= ekxjxik
2=2s2 : 4
The linear SVM procedure is then applied to the feature
vectors in this feature space and the decision function for their
classification is given by
f xð Þ = sign
Xl
i¼1
a0i yiK x, xið Þ + b
" #
, 5
where the coefficients ai0 and b are determined by maximizing
the following Langrangian expression:
Xl
i¼1
ai  1
2
Xl
i¼1
Xl
j¼1
aiajyiyjK xi, xj
 
, 6
under conditions,
ai  0 and
Xl
i¼1
aiyi = 0 7
A positive or negative value from Equation 3 or Equation 5
indicates that the vector x belongs to the positive or negat-
ive group, respectively. To further reduce the complexity of
Figure 1. The sequence of a hypothetic protein for illustration of derivation of the feature vector of a protein. Sequence index indicates the position of an amino acid in
the sequence. The index for each type of amino acids in the sequence (A or E) indicates the position of the first, second, third, . . . of that type of amino acid (the
position of the first, second, third, . . . , A is at 1, 3, 4, . . . ). A/E transition indicates the position of AE or EA pairs in the sequence.
Table 2. Characteristic descriptors of human insulin precursor (Swiss-Prot AC P01308)
Property Elements of descriptors
Amino acid composition 9.09 5.45 1.82 7.27 2.73 10.91 1.82 1.82 1.82 18.18
1.82 2.73 5.45 6.36 4.55 4.55 2.73 5.45 1.82 3.64
Hydrophobicity 24.55 38.18 37.27 15.60 16.51 30.28 5.45 40.91 54.55 80.00
100.0 1.82 21.82 47.27 68.18 98.18 0.91 12.73 37.27 72.37
99.09
Van der waals volume 40.00 41.82 18.18 29.36 11.01 13.76 1.82 21.82 52.73 71.82
99.09 2.73 25.45 56.36 78.18 100.0 0.91 15.45 41.82 50.00
98.18
Polarity 40.91 32.73 26.36 24.77 20.18 13.76 0.91 14.55 38.18 74.55
99.09 1.82 20.91 49.09 68.18 91.82 5.45 33.64 53.64 79.09
100.0
Polarizability 29.09 52.73 18.18 31.19 9.17 15.60 1.82 21.82 52.73 68.18
91.82 2.73 25.45 56.36 79.09 100.0 0.91 15.45 41.82 50.00
98.18
The feature vector of this protein is constructed by combining all of the descriptors in sequential order.
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parameter selection, hard margin SVM with threshold instead
of soft margin SVM with threshold is used in SVMProt.
Scoring of SVM classification of proteins has been estim-
ated by a reliability index and its usefulness has been demon-
strated by statistical analysis (34). A slightly modified
reliability score, R-value, is used in SVMProt:
R-value =
1 if d < 0:2
d=0:2 þ 1 if 0:2  d < 1:8
10 if d  1:8
8><
>: 8
where d is the distance between the position of the vector of a
classified protein and the optimal separating hyperplane in the
hyperspace. There is a statistical correlation between R-value
and expected classification accuracy (probability of correct
classification) (34). Thus another quantity, P-value, is intro-
duced to indicate the expected classification accuracy. P-value
is derived from the statistical relationship between the R-value
and actual classification accuracy based on the analysis of
9932 positive and 45 999 negative samples of proteins (25).
RESULTS AND DISCUSSION
The protein functional family prediction system SVMProt is
improved by using training sets of a significantly larger num-
ber of proteins than that reported earlier (25,27). The training
and testing sets consist of 49 975 representative enzymes from
46 functional families obtained from UniProt version 1.6, and
243 152 non-enzyme representative proteins from 7316 Pfam
curated protein families (35). Enzyme functional families
are the International Commission (EC) classes (37) up to
the second level (from EC1.1 to EC6.5). The procedure for
selecting positive samples of a family is as follows. First, all
members of this family in UniProt 1.6 are collected and sub-
sequently mapped into the original feature space which is
divided into small grid blocks, then one or a few distinct
enzymes are selected from those distributed in each of
these blocks are selected as the training set of that family.
Enzymes in the testing and independent sets are randomly
selected from the remaining pool of family members. The
negative samples of a family are selected from representative
proteins of Pfam families that are non-enzymes or enzymes of
other enzyme families.
The statistics of the datasets and the prediction results as
well as SVMProt can be accessed at http://jing.cz3.nus.edu.sg/
cgi-bin/svmprot.cgi. An independent set of 13 891 enzymes
and 122 710 non-enzymes are used to assess the capability of
SVM for assignment of enzymes into their respective family
(sensitivity) and for assignment of non-member proteins out-
side that family (specificity). The sensitivity is >85% for
9 families, 70–85% for 21 families, 60–70% for 10 families
and 53–60% for 6 families. The specificity is >95% for
38 families and 82–95% for 8 families.
The overall sensitivity for all of the 13 891 enzymes is 86%,
which is improved against the accuracy of 68% for the assign-
ment of 14 709 enzymes into their respective EC second level
class by using one or more of the three statistical learning
methods discretized naı¨ve Bayes, C4.5 decision trees, and
instance-based leaning (22). SVM has also been used for clas-
sification of enzymes into structural families irrespective of
sequence similarity, and the accuracy for assignment of
1178 enzymes is 80% (32). These suggest that statistical learn-
ing methods are useful for functional and structural family
assignment. The overall sensitivity is however slightly
lower than that of 92% for the BLAST assignment of the
EC class of 12 900 enzymes (38). Non-the-less, as these are
to a certain extent independent of sequence similarity, statist-
ical learning methods such as SVM are useful alternative for
studying novel proteins whose function cannot be assigned on
the basis of sequence similarity.
Enzymes without a homolog of known function are
searched from the Swiss-Prot database (13) by using the
key word ‘novel’, ‘distinct’, or ‘unrelated’ combined with
‘enzyme’. The next step is to eliminate those with at least
one homolog of known function (except for hypothetical pro-
teins) by conducting a PSI-BLAST (1) search against the
NR databases that include all non-redundant GenBank,
CDS translations, PDB, Swiss-Prot, PIR and PRF databases.
This ensures that only those truly having no homolog in pro-
tein databases are selected. While the selected enzymes from
this process are without a homolog, their function has been
determined experimentally and these have been reported in the
literature and subsequently described in the Swiss-Prot data-
base. The last step is to remove those present in the SVMProt
training sets.
Table 3 gives the 12 enzymes without a homolog in the NR
databases (group NR) and additional 38 enzymes without a
homolog in the Swiss-Prot database (group SP) selected from
this process, none of which are in the SVM training sets; 8 out
of 12 (67%) enzymes in group NR and 28 out of 38 (73.7%)
enzymes in group SP are correctly assigned to the respective
family by SVMProt. The overall accuracy is 72% which is
comparable to the average sensitivity for the enzyme families
and it is consistent with the sequence-similarity-independent
nature of SVM functional assignment. To further facilitate the
testing of SVMProt for functional family assignment of novel
proteins, a number of proteins of unknown function are
selected. These proteins are either without a homolog or with-
out functional indication in Swiss-Prot or NR database as of
September 2004 based on PSI-BLAST search. The predicted
functional classes of these proteins are given in the Supple-
mentary Material.
There are eight pairs of homologous enzymes of different
families from previous publications (8,27) that satisfy the
stricter criterion, which together with SVMProt predicted
top family for each enzyme are given in Table 4. It is
found that 5 or 62% of these enzyme pairs are correctly
assigned by SVMProt, such an accuracy is comparable to
the average sensitivity for the enzyme families and indicative
of the sequence-similarity-independent nature of SVM func-
tional assignment.
These results suggest that SVM has some capability for
functional family assignment of novel proteins having no
homolog, and for distinguishing homologous proteins of dif-
ferent functions. The overall accuracy of SVM is not yet at the
same level of that of sequence alignment for homologous
proteins. One reason is the imbalance between the number
of positive and negative samples. The total number of distinct
enzymes in some families is <200, which is significantly smal-
ler than that of a few thousand representative proteins used as
the negative samples of the respective family. Such a large
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Table 3. List of enzymes without a homolog in the NR and Swiss-Prot databases and the results of SVM functional family assignment
Enzyme (EC number) [Swiss-Prot accession number] Database containing
no homolog
SVM assigned functional family
(probability of correct prediction)
Assignment
status
Thiocyanate hydrolase beta subunit (EC 3.5.5.8)
[O66186].
NR EC 3.5 Hydrolase of non-peptide carbon–nitrogen bonds
(98.9%)
+
EC 2.6 Transferases of nitrogenous groups (62.2%)
Potential cysteine protease avirulence protein avrPpiC2
(EC 3.4.22.-) [Q9F3T4].
NR EC 4.2 Carbon–oxygen lyase (93.6%) 
EC 2.3 Acyltransferase (83.9%)
EC 4.1 Carbon–carbon lyase (71.3%)
Outer membrane (58.6%)
Extracellular phospholipase (EC 3.1.1.5) [P82476] NR EC 3.1 Hydrolase of ester bonds (98.7%) +
Cytochrome c oxidase polypeptide IV, mitochondrial
precursor (EC 1.9.3.1) [P30815].
NR EC 1.9 Oxidoreductase of a heme group of donors
(99.0%)
+
Cytochrome c oxidase polypeptide VI (EC 1.9.3.1)
[P26310].
NR EC 1.9 Oxidoreductase of a heme group of donors
(98.4%)
+
Transmembrane (98.3%)
EC 3.1 Hydrolase of ester bonds (62.2%)
Alginate lyase precursor (EC4.2.2.3) [P39049]. NR Transmembrane (65.4%) 
Outer membrane (58.6%)
EC 2.1 Transferase of one-carbon groups (58.6%)
DNA a-glucosyltransferase (EC 2.4.1.26) [P04519] NR EC 2.4 Glycosyltransferase (80.4%); +
EC 2.7 Transferase of phosphorus-containing groups
(68.5%)
Endonuclease CviAII (EC 3.1.21.4 [P31117] NR EC 3.1 Hydrolase of ester bonds (99.0%) +
Type II restriction enzyme CviJI (EC 3.1.21.4) [P52283] NR EC 3.1 Hydrolase of ester bonds (99.0%); +
rRNA-binding proteins (98.8%);
EC 3.4 Peptidase (68.5%)
DNA-directed RNA polymerase, subunit 10 homolog
(EC 2.7.7.6) [P42488]
NR EC 2.7 Transferase of phosphorus-containing groups
(99.0%)
+
7 transmembrane receptor metabotropic glutamate
family (58.6%)
Endonuclease IV (EC 3.1.21.-) [P39250] NR No function predicted 
Beta-agarase precursor (EC3.2.1.81) [P13734]. NR EC 4.1 Carbon–carbon lyase (96.7%) 
EC 2.4 Glycosyltransferase (71.3%)
Phenylacetaldoxime dehydratase (EC 4.2.1.-) [P82604]. Swiss-Prot Transmembrane (98.2%) 
EC 3.4 Peptidase (96.4%)
EC 3.3 Hydrolase of ether bonds (80.4%)
EC 2.7 Transferase of phosphorus-containing groups
(73.8%)
ATP synthase H chain, mitochondrial precursor
(EC3.6.3.14) [Q12349].
Swiss-Prot EC 3.6 Hydrolase of acid anhydrides (99.0%) +
RNA-binding protein (58.6%)
Peptide-N(4)-(N-acetyl-b-D-glucosaminyl)asparagine
amidase F precursor (EC 3.5.1.52) [P21163]
Swiss-Prot EC 3.5 Hydrolase of non-peptide carbon–nitrogen bonds
(99.0%)
+
Beta-Barrel porin (58.6%)
S-Adenosyl-L-methionine hydrolase (EC 3.3.1.2)
[P07693]
Swiss-Prot EC 3.3 Hydrolase of ether bonds (99.0%) +
EC 2.7 Transferase of phosphorus-containing groups
(71.3%)
DNA-binding protein (65.4%)
Hypothetical 52.8 kDa protein in VPS15-YMC2
intergenic region .(EC 3.1.22.-) [P38257]
Swiss-Prot DNA-binding protein (89.3%) 
Outer membrane (58.6%)
Hypothetical protein BBB03 (EC3.1.22.-) [O50979]. Swiss-Prot EC 2.7 Transferase of phosphorus-containing groups
(88.1%)

EC 3.4 Peptidase (86.8%)
EC 2.3 Acyltransferase (71.3%)
EC 4.1 Carbon–carbon lyase (65.4%)
Telomere elongation protein (EC2.7.7.-) [P17214]. Swiss-Prot EC 2.7 Transferase of phosphorus-containing groups
(99.1%)
+
DNA-binding protein (78.4%)
Fucose-1-phosphate guanylyltransferase (EC 2.7.7.30)
[O14772]
Swiss-Prot EC 2.7 Transferase of phosphorus-containing groups
(99.1%)
+
7 transmembrane receptor metabotropic glutamate
family (58.6%)
DNA-directed RNA polymerase I 14 kDa polypeptide
(EC 2.7.7.6) [P50106].
Swiss-Prot EC 2.7 Transferase of phosphorus-containing groups
(99%)
+
DNA-binding protein (62.2%)
Beta-Barrel porin (58.6%)
EC 3.4 Peptidase (58.6%)
DNA polymerase III, theta subunit (EC 2.7.7.7)
[P28689].
Swiss-Prot EC 2.7 Transferase of phosphorus-containing groups
(99.0%)
+
EC 4.2 Carbon–oxygen lyase (58.6%)
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Table 3. Continued
Enzyme (EC number) [Swiss-Prot accession number] Database containing
no homolog
SVM assigned functional family
(probability of correct prediction)
Assignment
status
Cytochrome c oxidase polypeptide IV (EC 1.9.3.1)
[P77921]
Swiss-Prot EC 1.9 Oxidoreductase of a heme group of donors
(97.0%)
+
Envelope protein (58.6%)
Transmembrane (58.6%)
Cytochrome c oxidase polypeptide VII (EC 1.9.3.1)
[P10174].
Swiss-Prot EC 1.9 Oxidoreductase of a heme group of donors
(98.3%)
+
Transmembrane (58.6%)
Cytochrome c oxidase polypeptide VIII, mitochondrial
precursor (EC 1.9.3.1) [P04039].
Swiss-Prot EC 1.9 Oxidoreductase of a heme group of donors
(99.0%)
+
Transmembrane (58.6%)
RNA-binding protein (58.6%)
Cytochrome c oxidase polypeptide VIIA precursor
(EC1.9.3.1) [P07255].
Swiss-Prot EC 1.9 Oxidoreductase of a heme group of donors
(97.8%)
+
Transmembrane (93.8%)
EC 1.10 Oxidoreductase of diphenols and related
substances as donors (58.6%)
Alpha-type channel (58.6%)
Heme-copper oxidase subunit IV (EC 1.9.3.-)
[Q9YDX4].
Swiss-Prot EC 1.9 Oxidoreductase of a heme group of donors
(99.0%)
+
Transmembrane (99.0%)
Aminoglycoside 20-N-acetyltransferase (EC 2.3.1.-)
[P95219]
Swiss-Prot EC 2.7 Transferase of phosphorus-containing groups
(78.4%)

EC 4.2 Carbon–oxygen lyase (58.6%)
Glycosyl transferase alg8 (EC2.4.1.-) [Q887P9]. Swiss-Prot Transmembrane (99.0%) *
EC 2.4 Glycosyltransferase (98.6%)
Beta-agarase B (EC 3.2.1.81) [P48840]. Swiss-Prot Outer membrane (58.6%) 
Beta-Barrel porin (58.6%)
CM (EC 5.4.99.5) [P19080] Swiss-Prot EC 5.4. Intramolecular transferase (99.0%) +
EC 4.2. Carbon–oxygen lyase (58.6%)
Outer membrane (58.6%)
DNA b-glucosyltransferase (EC 2.4.1.27) [P04547] Swiss-Prot EC 2.4 Glycosyltransferases (95.7%); +
EC 2.5 Transferase of alkyl or aryl groups, other than
methyl groups (80.4%)
dNMPkinase (EC 2.7.4.13) [P04531] Swiss-Prot EC 2.7 Transferase of phosphorus-containing groups
(99.0%);
+
EC 2.4 Glycosyltransferase (96.4%);
EC 1.1 Oxidoreductase of the CH-OH group of donors
(71.3%)
Endonuclease II (EC 3.1.21.1) [P07059] Swiss-Prot EC 3.1 Hydrolase of ester bonds (99.0%) +
Endonuclease V (EC 3.1.25.1) [P04418] Swiss-Prot EC 3.1 Hydrolase of ester bonds (99.0%) +
Exonuclease (EC 3.1.11.3) [P03697] Swiss-Prot EC 3.1 Hydrolase of ester bonds (99.0%); +
EC 4.1 Carbon–carbon lyases (88.1%);
EC 2.7 Transferase of phosphorus-containing groups
(68.5%);
EC 1.1 Oxidoreductase of the CH-OH group of donors
(58.6%)
Ribonuclease (EC 3.1.-.-)[P13312] Swiss-Prot EC 3.1 Hydrolase of ester bonds (99.0%) +
Intron-associated endonuclease 1 (EC 3.1.-.-) [P13299] Swiss-Prot EC 3.1 Hydrolase of ester bonds (99.0%); +
DNA-binding protein (83.9%)
Intron-associated endonuclease 2 (EC 3.1.-.-) [P07072] Swiss-Prot EC 3.1 Hydrolase of ester bonds (99.0%) +
Putative adenine-specific methylase (EC 2.1.1.72)
[P51715]
Swiss-Prot EC 2.1 Transferase of one-carbon groups (99.0%); +
Outer membrane (58.6%);
mRNA-binding protein (58.6%)
Protein kinase (EC 2.7.1.37) [P00513] Swiss-Prot EC 2.7 Transferase of phosphorus-containing groups
(99.0%)
+
Slt35 (EC 3.2.1.-) [P41052] Swiss-Prot Outer membrane (99.0%) 
EC 1.1. Oxidoreductase acting on the CH-OH group of
donors (89.3%)
EC 4.1. Carbon–carbon lyase (62.2%)
Ammonia monooxygenase (EC 1.13.12.-)[Q04508] Swiss-Prot EC 1.13. oxygenase (99.0%) +
Transmembrane (99.0%)
EC 2.4. Glycosyltransferases (83.9%)
2-Aminomuconate deaminase (EC 3.5.99.5) [P81593] Swiss-Prot EC 3.5. Hydrolase acting on carbon–nitrogen bonds,
other than peptide bonds (99.0%)
+
EC 3.4. Peptidase (58.6%)
ADP-ribosyltransferase (EC2.4.2.37) [P14299] Swiss-Prot Transmembrane (92.9%) *
EC 2.4. Glycosyltransferase (90.3%)
Outer membrane (58.6%)
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data imbalance is known to affect the accuracy of a SVM
classification system, and methods for solving these problems
are being developed (39). It is likely that not all possible types
of proteins, particularly those of distantly related members, are
adequately represented in some families. This can be improved
along with the availability of more protein data. Not all dis-
tantly related proteins of the same function have similar struc-
tural and chemical features due to the flexibility at the active
site (17). This plasticity needs to be properly formulated.
These improvements will enable the development of SVM
into a useful tool for facilitating functional study of novel
proteins.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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